ERIS.NS(ERIS.NS)
ERIS.NS
No analyst ratings available
No analyst price targets available for ERIS.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $35.39B | $40.10B | $44.91B | $52.00B |
| Low | $34.99B | $39.04B | $43.38B | $50.82B |
| High | $36.09B | $41.17B | $46.31B | $53.31B |
| EBITDA Avg | $11.84B | $14.67B | $17.24B | $18.91B |
| Low | $11.56B | $13.60B | $15.33B | $18.56B |
| High | $12.98B | $15.80B | $18.58B | $19.29B |
| EBIT Avg | $8.45B | $10.66B | $12.57B | $13.49B |
| Low | $8.17B | $9.59B | $10.66B | $13.14B |
| High | $9.59B | $11.79B | $13.92B | $13.88B |
| Net Income Avg | $6.03B | $8.00B | $9.71B | $10.52B |
| Low | $5.78B | $7.04B | $8.00B | $10.21B |
| High | $7.05B | $9.01B | $10.90B | $10.87B |
| EPS Avg | $46.43 | $59.50 | $70.01 | $77.00 |
| Low | $42.29 | $51.52 | $58.54 | $74.72 |
| High | $51.56 | $65.92 | $79.79 | $79.53 |
| Analysts (Rev / EPS) | 9 / 8 | 10 / 9 | 6 / 6 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $8.90B | $9.13B | $8.87B |
| Low | $8.90B | $9.13B | $8.87B |
| High | $8.90B | $9.13B | $8.87B |
| EBITDA Avg | $2.96B | $3.45B | $3.23B |
| Low | $2.96B | $3.45B | $3.23B |
| High | $2.96B | $3.45B | $3.23B |
| EBIT Avg | $2.20B | $2.66B | $2.40B |
| Low | $2.20B | $2.66B | $2.40B |
| High | $2.20B | $2.66B | $2.40B |
| Net Income Avg | $1.54B | $1.95B | $1.72B |
| Low | $1.54B | $1.95B | $1.72B |
| High | $1.54B | $1.95B | $1.72B |
| EPS Avg | $11.30 | $14.30 | $12.60 |
| Low | $11.30 | $14.30 | $12.60 |
| High | $11.30 | $14.30 | $12.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |